Drug Profile
ELB 176
Alternative Names: AWD-34-176Latest Information Update: 24 Aug 2007
Price :
$50
*
At a glance
- Originator elbion
- Class Antiepileptic drugs; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 02 Sep 2005 No development reported - Preclinical for Epilepsy in Germany (unspecified route)
- 18 Sep 2002 Preclinical trials in Epilepsy in Germany (unspecified route)